European Research Initiative on CLL

  • 11/01/2017 Innovative medicines initiative approves project for better care of patients with hematologic malignancies
  • 22/12/2016 ERIC acknowledged for the award received by Dr Panagiotis Baliakas for the best hematology thesis in Sweden 2016
  • 20/12/2016 2nd round of IG certification is now OPEN! 2nd round begins on 15 January!
  • 29/11/2016 Click here for more information on the Design your e-infrastructure workshop which took place in Kraków, Poland on 27 September 2016
  • 29/09/2016 14th Annual Symposium of the European LeukemiaNet (ELN) 31 January - 1 February 2017
View All


ERIC is a European organization devoted to improving the outcome of patients with chronic lymphocytic leukemia (CLL) and related diseases.

There are many more open questions and new drugs available for the treatment of CLL than there are study groups or active protocols. To achieve faster progress, open communication between study groups, physicians and scientists is essential.

ERIC is a Working Party of the European LeukemiaNet and a Scientific Working Group of the European Hematology Association. ERIC is open to all physicians and scientists working or interested in the field of chronic lymphocytic leukemia and related disorders.